Literature DB >> 23763589

Hepatitis E virus in Scottish blood donors.

A Cleland1, L Smith, C Crossan, O Blatchford, H R Dalton, L Scobie, J Petrik.   

Abstract

BACKGROUND AND OBJECTIVES: Published prevalence figures for hepatitis E virus (HEV) reveal significant regional differences. Several studies have reported virus transmission via blood transfusion. The aim of this study was to establish HEV seroprevalence and investigate a potential HEV RNA presence in Scottish blood donors.
MATERIALS AND METHODS: IgG and IgM were determined in individual serum samples. HEV RNA was investigated in plasma mini-pools corresponding to 43 560 individual donations using nested PCR. Samples amenable to reamplification with primers from a different region were considered confirmed positives, sequenced and analysed.
RESULTS: A total of 73 of 1559 tested individual sera (4·7%) were IgG positive, none tested positive for IgM. Plasma mini-pool testing revealed an HEV RNA frequency of 1 in 14 520 donations. Three confirmed positives belonged, as expected to genotype 3.
CONCLUSIONS: HEV IgG and RNA figures in Scottish blood donors are lower than those published for the rest of the UK, but sufficiently high to prompt further studies on potential transmission rates and effects of HEV infection, especially for immunosuppressed individuals.
© 2013 International Society of Blood Transfusion.

Entities:  

Keywords:  HEV; NAT testing; blood donors; serological testing

Mesh:

Substances:

Year:  2013        PMID: 23763589     DOI: 10.1111/vox.12056

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  42 in total

1.  Hepatitis e: the 'new kid on the block' or an old friend?

Authors:  Harry R Dalton
Journal:  Transfus Med Hemother       Date:  2014-02       Impact factor: 3.747

Review 2.  Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries.

Authors:  Nicola J King; Joanne Hewitt; Anne-Marie Perchec-Merien
Journal:  Food Environ Virol       Date:  2018-04-05       Impact factor: 2.778

Review 3.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

4.  Early hepatitis E infection in an unrelated hematopoietic progenitor stem cell donor.

Authors:  D O'Donghaile; N O'Flaherty; S Field
Journal:  Bone Marrow Transplant       Date:  2017-07-17       Impact factor: 5.483

Review 5.  Hepatitis E virus and neurological injury.

Authors:  Harry R Dalton; Nassim Kamar; Jeroen J J van Eijk; Brendan N Mclean; Pascal Cintas; Richard P Bendall; Bart C Jacobs
Journal:  Nat Rev Neurol       Date:  2015-12-29       Impact factor: 42.937

Review 6.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

7.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

8.  A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors.

Authors:  Enea Spada; Simonetta Pupella; Giulio Pisani; Roberto Bruni; Paola Chionne; Elisabetta Madonna; Umbertina Villano; Matteo Simeoni; Sara Fabi; Giuseppe Marano; Cinzia Marcantonio; Patrizio Pezzotti; Anna R Ciccaglione; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2018-05-04       Impact factor: 3.443

9.  Phage-displayed peptides that mimic epitopes of hepatitis E virus capsid.

Authors:  Osmany Larralde; Juraj Petrik
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

Review 10.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.